Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-25-241472

Chief Executive Officer sold 10,916 shares at an average $25.81 ($281,729)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ceesay Abraham Chief Executive Officer 2025-10-15 Sale 10b5-1 −4,647 $25.72 $119,539 580,765 D
Ceesay Abraham Chief Executive Officer 2025-10-15 Sale 10b5-1 −1,186 $26.14 $31,001 579,579 D
Ceesay Abraham Chief Executive Officer 2025-10-15 Sale 10b5-1 −4,328 $25.75 $111,429 41,816 I
Ceesay Abraham Chief Executive Officer 2025-10-15 Sale 10b5-1 −755 $26.17 $19,760 41,061 I
Open-market sales · 10,916 sh · avg $25.81 · $281,729
Loading xslF345X05/ownership.xml…